Video Highlights

Video Highlights

Diabetes in Asia: The Real Picture

Shih-Tzer Tsai, MD
Taipei Veterans General Hospital
Taipei, Taiwan

In this segment, Professor Tsai elucidates the rising epidemic of diabetes in East Asian countries and underscores the need for an holistic, individualized care plan for each diabetes patient. He cites recent clinical trials and publications that support the treatment of patients in this region, as they tend to exhibit differing characteristics than diabetes sufferers who reside outside of the Asian region.

Program Duration: 24:36
To provide comments, please click here

Old Choices and New Options in the Management of Hyperglycemia

Jamie A. Davidson, MD, FACP, MACE
Clinical Professor of Medicine
Division of Endocrinology
Touchstone Diabetes Center
University of Texas Southwestern Medical Center
Dallas, Texas, United States

This segment explains the reasoning behind treating to target and the importance of enhancing the quality of life of the diabetes patient. Dr. Davidson presents a comprehensive overview of not only the standard treatment options used to treat diabetes, but also those newer medications such as GLP-1 receptor agonists, SGLT-2 inhibitors, and DPP-4 inhibitors. He reviews clinical trial results that underscore safety and efficacy profiles.

Program Duration: 47:08
To provide comments, please click here

From Hypoglycemia to Weight Gain: How to Manage Side Effects of Diabetes Treatments?

Stephan Matthaei, MD, PhD
Director, Department for Diabetes, Metabolism and Endocrinology
Quakenbrück Hospital
Christian Hospital Clinical Diabetes Center
Teaching Hospital of the Medical University of Hanover
Quakenbrück, Germany

Professor Matthaei discusses the importance of focusing on glucose control, reaching an individualized treatment goal without causing side effects. This segment focuses on the importance of optimizing treatment to reduce both microvascular and microvascular diseases and elucidates the importance of preventing severe hypoglycemia. Professor Matthaei reviews the various classes of anti-diabetic agents available to achieve such results while managing deleterious side effects.

Program Duration: 28:08
To provide comments, please click here

Case-Based Insight: Managing Microvascular Complications

Juliana Chan, MBChB, MD, FHKAM, FRCP
Professor of Medicine and Therapeutics
Director, Hong Kong Institute of Diabetes and Obesity
Co-director, International Diabetes Federation Centre of Education
The Chinese University of Hong Kong
The Prince of Wales Hospital
Shatin, Hong Kong SAR, China

This case-based segment features an in-depth analysis of an actual patient, analyzing her treatment options and providing insights as to managing her disease with regard to potential microvascular complications. Professor Chan identifies not only the critical aspects of medical treatment, but also the importance of patient engagement, empowerment and evaluation.

Program Duration: 30:53
To provide comments, please click here

Managing Diabetes Patients in 2030 – What Will Be Our Approach?

Jae-Hyoung Cho, MD
Department of Endocrinology
Seoul St. Mary’s Hospital
Catholic University of Korea College of Medicine
Seoul, Korea

This segment features a look into the future of diabetes management, and gives the viewer an idea of medications, applications, and devices that are on the horizon, likely to become part of the physician’s treatment options in the near future. Professor Cho describes insulin replacement therapies, vaccines, remote and wireless monitoring applications, and smartphone applications that are poised to enhance the ways in which diabetes is managed and treated in the next few decades.

Program Duration: 18:40
To provide comments, please click here